These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 1323912)
1. [Pharmaceutic development of injectable Arduan]. Deákné RE; Guti Z; Rádi E Acta Pharm Hung; 1992 May; 62(3):115-20. PubMed ID: 1323912 [TBL] [Abstract][Full Text] [Related]
2. [Analysis of steroids. Part 44: Analytical investigation of the intermediates of the synthesis of pipecuronium bromide (Arduan)]. Laukó A; Horváth P; Trischler F; Görög S Acta Pharm Hung; 1992 May; 62(3):82-7. PubMed ID: 1323917 [TBL] [Abstract][Full Text] [Related]
3. [A pharmacodynamic study of pipecuronium bromide (Arduan) in newborn infants, infants and children]. Praefort L Cah Anesthesiol; 1990 Mar; 38(2):79-85. PubMed ID: 2163731 [TBL] [Abstract][Full Text] [Related]
4. [Graded continuous administration of arduan during surgery with prolonged hypothermic perfusion]. Sud'in VI; Lagutina AI; Suddason Ch Anesteziol Reanimatol; 1983; (6):5-8. PubMed ID: 6322619 [No Abstract] [Full Text] [Related]
5. Clinical experiences with pipecuronium bromide. Boros M; Szenohradszky J; Kertész A; Marosi G; Tutsek L Acta Chir Hung; 1983; 24(4):207-14. PubMed ID: 6322488 [TBL] [Abstract][Full Text] [Related]
6. [Synthesis of a new neuromuscular blocking agent, pipecuronium bromide (Arduan)]. Tuba Z; Mahó S Acta Pharm Hung; 1992 May; 62(3):73-81. PubMed ID: 1323916 [TBL] [Abstract][Full Text] [Related]
7. [Excerpts from the investigations of pipecuronium bromide with NMR spectroscopy]. Balogh G; Tuba Z Acta Pharm Hung; 1992 May; 62(3):97-102. PubMed ID: 1323919 [TBL] [Abstract][Full Text] [Related]
9. [Pharmacokinetics and metabolism of pipecuronium bromide (Arduan)]. Vereczkey L Acta Pharm Hung; 1992 May; 62(3):127-31. PubMed ID: 1323914 [TBL] [Abstract][Full Text] [Related]
10. Arduan muscle relaxation prolonged with norcuron. Fister T Ther Hung; 1991; 39(3):125-7. PubMed ID: 1687841 [TBL] [Abstract][Full Text] [Related]
11. [Determination of the protonation constants of pipecuronium bromide on the basis of optical rotation as a function of pH values]. Bertháné SZ; Papné SZ Acta Pharm Hung; 1992 May; 62(3):111-4. PubMed ID: 1323911 [TBL] [Abstract][Full Text] [Related]
12. [Mass spectrometry of pipecuronium bromide and some related compounds]. Mák M; Tamás J; Mahó S; Tuba Z Acta Pharm Hung; 1992 May; 62(3):103-9. PubMed ID: 1323910 [TBL] [Abstract][Full Text] [Related]
13. [Analysis of steroids. Part 45: Analytical investigation of pipecuronium bromide (Arduan)]. Gazdag M; Szepesi G; Mihályfi K; Kemenesné BP; Horváth P; Végh Z; Rényei M; Trischler F; Görög S Acta Pharm Hung; 1992 May; 62(3):88-96. PubMed ID: 1323918 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the neuromuscular blocking effect of Arduan. Tassonyi E Ther Hung; 1983; 31(1):13-7. PubMed ID: 6100820 [No Abstract] [Full Text] [Related]
15. [Clinicopharmacology of Arduan]. Mészáros C Acta Pharm Hung; 1992 May; 62(3):133-8. PubMed ID: 1354406 [TBL] [Abstract][Full Text] [Related]
16. [Pharmacologic effects of pipecuronium bromide (Arduan)]. Kárpáti E; Bíró K Acta Pharm Hung; 1992 May; 62(3):121-6. PubMed ID: 1323913 [TBL] [Abstract][Full Text] [Related]
19. Myasthenia gravis and pipecuronium--report of two cases. Naguib M; Sari-Kouzel A; Ashour M; Seraj M; Messahel F Middle East J Anaesthesiol; 1992 Feb; 11(4):381-90. PubMed ID: 1320731 [TBL] [Abstract][Full Text] [Related]
20. Interaction between nondepolarizing neuromuscular blocking agents and inhalational anesthetics. Swen J; Rashkovsky OM; Ket JM; Koot HW; Hermans J; Agoston S Anesth Analg; 1989 Dec; 69(6):752-5. PubMed ID: 2574015 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]